Fabentech raises €20.0M Growth round

7 October 2024· Lyon, France· health, biotech, materials, b2b, b2g, deep_hardware

The funding will accelerate R&D, bioproduction, commercialization, and expansion efforts, and strengthen the development and deployment of broad-spectrum therapeutics to combat the highest-priority biological threats to public health.

Investors

LeadEuropean Investment Bank

About Fabentech

Stage
Series A
Headquarters
Lyon, France
Founded
2009
Team Size
21–50
Sectors
healthbiotechmaterialsb2bb2gdeep_hardware

Source: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHRthJ_yQ0yqRo4bBtAArG32dp4R2k6aVg7BDAvaK4ZzX8Um4gaxta_LwHfeQ2OaFbas6zGFBAEMGs9-NpTr1Vl2VWtwcphYGFcgoFXWMNqqN5NO0fjvAOMzho_HPFqYfzWhsDvlmJ0oaI_MQuPXYplGsFNrBALTG30YC3L6mPSsacEmdvA70DdnpsmCfBugulNEu2lWaveL9FlAfu8L7FmAAn9Di0EcVFcId_muT97hVPH5vzB8JMCFYKcSnfSwI66BMVl91V7kwVtHmAt71_K8erT-XQEJ4XQ1sO5rwAL